Related Experiment Videos
Current treatment for hepatocellular carcinoma
Bridget A Cahill1, Deborah Braccia
1Department of Medicine, Northwestern Medical Faculty Foundation, Chicago, IL, USA. bcahill@nmff.org
Clinical Journal of Oncology Nursing
|September 10, 2004
Summary
Hepatocellular carcinoma (HCC) incidence is rising due to viral hepatitis and better diagnostics. Early detection improves treatment opportunities for this complex cancer.
Area of Science:
- Oncology
- Hepatology
Background:
- Hepatocellular carcinoma (HCC) is a globally prevalent cancer, ranking fifth worldwide.
- HCC incidence in the U.S. has surged by approximately 75% since the 1980s, linked to increased viral hepatitis infections and advanced diagnostics.
- Historically poor prognosis is improving with enhanced surveillance and imaging, enabling earlier detection and treatment.
Purpose of the Study:
- To provide an overview of the current, complex management strategies for Hepatocellular Carcinoma (HCC) in the United States.
- To inform oncology nurses about the multidisciplinary approach to HCC care.
- To highlight the evolving landscape of HCC diagnosis and treatment.
Main Methods:
- Review of diagnostic confirmation and staging procedures for HCC.
- Analysis of available treatment modalities, including surgical and nonsurgical options.
- Discussion of palliative care interventions for advanced HCC.
Main Results:
- Surgical options like hepatectomy and liver transplantation offer potential cure but are feasible for a minority of patients.
- Nonsurgical palliative treatments include ablative techniques, radiation, and systemic therapies.
- Earlier detection through improved surveillance and imaging enhances treatment opportunities.
Conclusions:
- Effective management of HCC requires a multidisciplinary team approach.
- Oncology nurses must stay informed about the latest HCC diagnostic and therapeutic advancements.
- Despite challenges, advancements in detection and treatment offer improved outcomes for HCC patients.